Background Routine delirium screening could improve delirium detection, but it remains unclear as to which screening tool is most suitable. We tested the diagnostic accuracy of the following screening methods (either individually or in combination) in the detection of delirium: MOTYB (months of the year backwards); SSF (Spatial Span Forwards); evidence of subjective or objective ‘confusion’.
Methods We performed a cross-sectional study of general hospital adult inpatients in a large tertiary referral hospital. Screening tests were performed by junior medical trainees. Subsequently, two independent formal delirium assessments were performed: first, the Confusion Assessment Method (CAM) followed by the Delirium Rating Scale-Revised 98 (DRS-R98). DSM-IV (Diagnostic and Statistical Manual of Mental Disorders, fourth edition) criteria were used to assign delirium diagnosis. Sensitivity and specificity ratios with 95% CIs were calculated for each screening method.
Results 265 patients were included. The most precise screening method overall was achieved by simultaneously performing MOTYB and assessing for subjective/objective confusion (sensitivity 93.8%, 95% CI 82.8 to 98.6; specificity 84.7%, 95% CI 79.2 to 89.2). In older patients, MOTYB alone was most accurate, whereas in younger patients, a simultaneous combination of SSF (cut-off 4) with either MOTYB or assessment of subjective/objective confusion was best. In every case, addition of the CAM as a second-line screening step to improve specificity resulted in considerable loss in sensitivity.
Conclusions Our results suggest that simple attention tests may be useful in delirium screening. MOTYB used alone was the most accurate screening test in older people.
This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/
Statistics from Altmetric.com
Delirium is a serious neuropsychiatric condition which occurs in the setting of acute illness. It is ubiquitous in the acute hospital setting, having a point prevalence of almost 20%,1 with higher rates in older patients. It is independently associated with adverse outcomes,2 including increased length of stay, increased mortality and accelerated cognitive and functional decline.
A major challenge in delirium care is that, despite its significance, delirium is commonly missed or mistaken for other conditions across treatment settings. In a point-prevalence study of delirium in 311 patients across a general hospital, doctors missed over half the delirium cases.1 In a study of general hospital referrals to liaison psychiatry, Kishi et al showed that 46% of delirium diagnoses were missed by the referring team.3 Detection rates are lower in older patients,4 those with premorbid dementia5 and in hypoactive cases.6 ,7 Collins et al found recognition rates to be as low as 28% in older medical inpatients8 and studies in the emergency department (ED) show similar rates of underdetection.9 ,10 The reasons for poor recognition are multifactorial. ‘Confusion’ is commonly considered normal in older patients, who are most at risk. The symptom profile varies greatly from patient to patient, and the prevailing stereotype of hyperactive delirium (‘delirium tremens’) is misleading, as delirium most commonly presents in its less obvious and more serious hypoactive form. Clinicians may also be deceived by patients during periods of lucidity, as the symptoms characteristically fluctuate over the course of the day. Studies have shown the importance of early recognition and intervention in reducing the severity and duration of delirium.11 Although studies investigating impact of early intervention on long-term outcomes have been inconsistent, Gonzalez and colleagues found an 11% increase in mortality with every additional 48 h of delirium,12 and Kakuma et al13 reported a significant increase in mortality at 6 months in older patients with undetected delirium discharged from the ED, compared to those with delirium who had been appropriately diagnosed.
Ideally, all patients at high risk of delirium should be assessed regularly using systematic application of sensitive tools. However, formal delirium diagnosis is based on thorough, and often lengthy, assessment by a trained and experienced clinician. Hence, a two-phase approach to detection is most efficient: first, screening for key delirium features using a simple, short test, followed by formal assessment in those who screen positive. The recent National Institute of Health and Care Excellence (NICE) guidelines advocate this approach,14 and recommend daily screening for all those at risk. Currently, consensus is lacking as to which screening method is best, but it is clear that test sensitivity must be emphasised over specificity to minimise the dangers of missed cases. The NICE guidelines screening approach is based on monitoring for a list of specific delirium indicators, however, this method has yet to be validated and likely requires some understanding of delirium in order to ensure accurate application. The most widely used screening test is the Confusion Assessment Method (CAM)15 ,16 which has been validated in several languages and settings.17 This tool, designed for delirium diagnosis, was based on DSM-IIIR (Diagnostic and Statistical Manual of Mental Disorders, third edition) criteria. It requires training to ensure accuracy18 and lacks the brevity desired for routine general use.
The prevailing gold standard for delirium diagnosis at the time of the study was DSM-IV19 criteria applied by an experienced clinician following standardised testing. In order to be diagnosed with DSM-IV delirium, a patient must present with the following features: a disturbance of consciousness with reduced ability to focus, shift or sustain attention; a change in cognition or perception that is not explained by a pre-existing, established or evolving dementia; acute onset and fluctuating course; and evidence of an underlying general medical cause. Hence, inattention is a core delirium feature, mandatory to DSM-IV criteria diagnosis (reflected also in the recently published DSM-5 criteria).20 Attention is a basic component of cognitive function, and can affect performance in many other cognitive domains. It is affected in many disorders other than delirium, including dementia, depression and developmental conditions, such as attention-deficit hyperactivity disorder. Other factors which may impact negatively on measures of attention are level of education, female sex and increasing age,21–23 however reports are conflicting.22 ,24 ,25 Attention is particularly affected in Dementia with Lewy Bodies (DLB), which is phenomenologically and neurochemically more similar to delirium than other dementias.26 In Alzheimer's dementia (AD), complex attentional functions are affected early on in the disease with performance on more basic attention tasks relatively preserved until the advanced stages of the condition,27 however, it is thought that the deficits may be reflective of more primary memory problems.28 Contrastingly, in delirium, the attentional deficit is more global, more marked, and being a mandatory feature of delirium, occurs with much higher frequency than other cognitive deficits.29 Bedside tests to capture inattention are simple and quick to perform, and include ‘WORLD backwards’ and ‘serial 7s’ from Folstein's Mini Mental State Examination (MMSE),30 and reciting the months of the year or the days of the week backwards.31 ,32 The former two tests from the MMSE are well recognised to be particularly sensitive to educational level.33 Other examples, such as the Digit Span Test, the Vigilance ‘A’ Test, and the Digit Cancellation Test have been shown to aid delirium detection.34 ,35 The visual Spatial Span Forwards (SSF), a pattern recognition test based on the digit span forwards,36 has recently shown to be of some use in identifying inattention in patients with delirium versus those with dementia.37 These bedside tests are somewhat observer-dependent, and may be affected by deficits in other domains, such as visual or auditory processing speed and motor execution. The Edinburgh Delirium Test Box is a device which was developed specifically to objectively measure performance on tasks of sustained visual attention only. Using this device, Brown and colleagues showed that patients with delirium performed much more poorly on sustained attention tasks than those with AD or healthy controls. Additionally, the device showed excellent accuracy for discriminating delirium from dementia and cognitively intact controls.38 Using devices such as this, however, is cumbersome and, hence, we considered simple bedside tests, which require minimal training, to be more feasible for routine and repeated use in a busy clinical setting. Thus, the aim of our study was to determine if the simple bedside attention tests, Months of the Year Backwards (MOTYB) and SSF, or reports of confusion (either subjective or objective) were predictive of the presence of delirium. We also aimed to assess the usefulness of the CAM, as a second-line screening step following initial testing.
This study was part of a large point-prevalence study of delirium, which was conducted at Cork University Hospital (CUH) on 15th May 2010. The details of this study's methodology and ethical procedures have been published elsewhere.1 All adult inpatients were eligible for inclusion in the study, excluding those in the ED, intensive care unit and haematology/burns isolation unit. Patients were also excluded if they refused participation, or were severely aphasic; comatose; dying; or considered too unwell for interview by nursing staff.
The study involved three stages of assessment: attention testing/screening for subjective or objective ‘confusion’; CAM assessment; and formal evaluation by experienced psychiatrists. Trained junior medical staff first screened every patient for inattention using the SSF and MOTYB. The SSF was performed using an A5-sized piece of white card with eight red squares (each measuring 1.5 cm2) evenly spaced over three rows (configuration three, two, three; landscape; see online supplementary files). The investigators tapped out predetermined sequences for the patients to replicate. The test began with a sequence of two squares and increased in number with each correct iteration, up to a maximum sequence of seven. Two attempts were allowed at each level using different predetermined sequences. Patients who were unable to correctly repeat a sequence of five were considered to have failed the test. For the MOTYB, the patients were first requested to say the months of the year forward from January to December. They were then asked to recite the months in reverse order from December back to January. Patients were considered to have passed this test on reaching July without error. Hence, inattention was deemed present in those who scored less than five on SSF, or were unable to correctly recite the MOTYB as far as July. Additionally, the patient was screened for subjective confusion, and objective reports of confusion (or proxy terms) by nursing staff interview and inspection of the medical notes. The patients were asked the following question: ‘Have you felt muddled in your thinking, or confused, since you came into hospital?’ to determine the presence of subjective confusion. The nurses were interviewed using a standardised set of questions (available as an online supplementary file and published elsewhere1), used to investigate the presence or absence of delirium features. The medical notes were also searched for any documentation of delirium or the proxy terms ‘confusion’ or ‘agitation’ during the admission. The patient was considered to have objective evidence of confusion if nursing staff responded positively to any of the nursing questions relating to delirium, and/or if there was reference to delirium or proxy term in the medical notes.
Patients who failed at least one of the attention tests, or who had subjective or objective reports of confusion, were then independently assessed using the sensitive, short form of the CAM, by a team of eight trained Geriatric Medicine registrars and consultants,39 and deemed either CAM-positive or CAM-negative. These doctors had undergone 8 h of CAM training over a 3-month period, including instruction, discussion, simulated cases, interval online self-assessment and, finally, trainer-observed CAM performance and scoring with feedback. Table 1 illustrates how each item on the CAM was scored. Of note, the SSF and MOTYB were repeated by the CAM assessors for the purposes of scoring the CAM.
Patients who underwent CAM then proceeded to be assessed by a team of four experienced psychiatrists, with specific expertise in delirium detection, using the Delirium Rating Scale–Revised '98 (DRS-R98)40 (time to psychiatry assessment <24 h). This is a well-validated,40–42 diagnostically precise tool which displays high inter-rater reliability, validity, sensitivity and specificity for differentiating delirium from mixed neuropsychiatric conditions including dementia and depression.40 ,42 ,43 This assessment was performed completely independently of the two previous stages, and all items were scored according to the DRS-R98 training manual.44The presence of delirium was ultimately determined according to DSM-IV criteria (reference standard).
Assessment of previous cognitive status
In all patients with delirium, the medical case-notes were reviewed for a diagnosis of pre-existing dementia made by a suitably trained physician. Where this was not available, premorbid cognition was determined by telephone interview using the Informant Questionnaire on Cognitive Decline in the Elderly-Short Form (IQCODE-SF), a validated screening tool for detecting dementia.45 ,46 Patients without delirium who were less than 65 years of age were presumed not to have dementia unless it was documented in the case notes. As dementia is more prevalent and is known to be underdetected in older people, depending on medical chart documentation for diagnosis was likely to be highly undersensitive. Hence, a random sample of 40 older non-delirious patients also had baseline preadmission cognition assessed using the IQCODE-SF.
Other data collected
Information relating to medication use was documented, and laboratory results (sodium, glucose, thyroid stimulating hormone, calcium, urea, C-reactive protein, white cell count and albumin level) were also collected. Current and previous alcohol history was recorded where available, and the Charlson comorbidity index47 was calculated.
Statistical analysis was performed using SPSS V.18. To compare baseline characteristics between patients with and without delirium, Mann–Whitney U-test was used. Sensitivities and specificities were calculated for each screening test/combination of tests from 2×2 tables, with CIs testing significance at 95%. Each screening method was assessed in this way initially in isolation, and then subsequently in combination with other screening methods. Hence, we examined the performance of a variety of test combinations. This included applying test combinations simultaneously or sequentially, and then with or without the CAM as a further screening step. There are two potential simultaneous test combination scenarios: (1) screen positive if at least one test failed (figure 1A) and (2) screen positive if both tests failed (figure 1B). These two approaches were analysed separately. In sequential test combinations, the second test is only applied in the setting of a failed first test (figure 1C). Simultaneous testing in which a patient screens positive if either or both screening methods are failed (scenario 1) will always have a higher net sensitivity than either sequential tests or simultaneous tests where both tests must be failed to screen positive (scenario 2); however, there is a net loss in specificity. Sequential testing results in a net loss in sensitivity, but a net gain in specificity.48
A modified version of the Forest Plot viewer programme was used to create graphical representation of the data.49 As advancing age and prior history of dementia have previously been shown to be independent predictors of delirium in this cohort,1 we repeated all calculations in those older than and younger than the median age of 69 years, and in those with and without a previous history of dementia. In total, over 70 test combinations were analysed.
There were 311 patients included in the delirium point-prevalence study and 280 had full data available, 55 of whom were diagnosed with DSM-IV delirium (19.6%).1 For this analysis, 265 patients were included, 48 (18.1%) of whom had DSM-IV delirium. We excluded those who had not completed SSF and MOTYB testing (hence, excluding patients with severe visual difficulties and aphasia), and those who had not had subjective and/or objective ‘confusion’ status recorded (see figure 2). Patients who were deemed to have objective evidence of confusion are those who were reported as confused by nursing staff and/or had documentation of confusion in the medical notes. Of the included patients, 23 had no data pertaining to medical documentation of delirium and four had missing data in relation to nursing opinion. Patient demographics for this cohort are outlined in table 2. The median age of the cohort was 69 years (range 17–95) and 51.1% were men. Reason for admission was recorded in 84.9% (n=225) included patients. The most commonly documented reasons for admission were, first, to undergo procedure/surgery (n=39, 14.7%), followed by neurological causes (n=33, 12.5%), respiratory causes (n=31, 11.7%), cardiac causes (n=30, 11.3%) and malignancy/tumour (n=25, 9.4%).
Figure 3A illustrates the sensitivity, specificity and 95% CIs for each screening test individually, and additionally with a subsequent CAM assessment, in the prediction of delirium for the whole group. The most accurate single test was MOTYB, with a sensitivity of 83.3% (95% CI 69.8 to 92.5) and specificity of 90.8% (95% CI 86.1 to 94.3). SSF5 (SSF using a cutoff of 5: ie, a patient who can repeat a maximum sequence of four squares has inattention) was highly sensitive (91.7%, 95% CI 80 to 97.6) but lacked specificity (69.12%, 95% CI 62.5 to 75.2). However, SSF4 (using a cutoff of 4) missed almost one-quarter of delirium cases (sensitivity 77.1%, 95% CI 62.7 to 87.9). Figure 3A also illustrates that although the addition of the CAM as a second-line screening step predictably increased net specificity of each method, it led to considerable net loss in sensitivity. For example, of 265 included patients, 60 patients failed the MOTYB and proceeded to CAM assessment. Of these, 40 patients were subsequently diagnosed with DSM-IV delirium, 10 of whom were missed by the CAM, hence a sensitivity of 75%. Of the 20 patients without DSM-IV delirium, only three had been CAM-positive, yielding a specificity of 85%.
Following assessment of each individual test, we analysed the performance of a variety of test combinations, as described earlier. Figure 3B illustrates the most efficient test combinations for the prediction of delirium for the overall group (additional data in online supplementary files). Using simultaneous approach (scenario 1) appears most effective, in particular the combination labelled ‘CONF/MOTYB’, which means that the patient failed MOTYB, or was confused subjectively/objectively(CONF). This combination had a sensitivity of 93.8% (95% CI 82.8 to 98.6) and a specificity of 84.7% (95% CI 79.2 to 89.2) and was marginally more accurate than the simultaneous application (scenario 1) of MOTYB and SSF4, sensitivity of 93.8% (95% CI 82.8 to 98.6); specificity 81.1% (95% CI 75.2 to 86.1).
As mentioned earlier, analysis of test combinations was also performed in older and younger patients. Figures representing this data are available as supplementary material. The MOTYB as a single test was best for those over the median age of 69 years, having high sensitivity and specificity for prediction of delirium, 83.8% (95% CI 68 to 93.8) and 89.6% (95% CI 81.7 to 94.9). Contrastingly, for younger patients, many test options were highly accurate, the most precise being a simultaneous (scenario 1) combination of SSF4 and subjective/objective confusion (sensitivity 100%, 95% CI 73.3 to 100; specificity 87.5%, 95% CI 80.2 to 92.8) or SSF (cut-off 4) and MOTYB (sensitivity 100%, 95% CI 71.3 to 100; specificity 86.8%, 95% CI 79.4 to 92.2). In this younger subgroup, evidence of confusion alone, without the use of any attention test, was also highly predictive of delirium (sensitivity 90.9%, 95% CI 58.7 to 98.5; specificity 92.5%, 95% CI 86.2 to 96.5).
Pre-existing cognitive status, as outlined above, was ascertained in 194 patients. Four patients had a documented history of dementia in the medical notes, all of whom had delirium. A further 27 were considered to have pre-existing dementia based on an IQCODE-SF of ≥3.5. Prior cognitive impairment independently predicted a diagnosis of delirium (adjusted OR 15.3; CI 5.2 to 45.4, p<0.001).1 In patients with dementia, MOTYB was again the most sensitive single test (87.5%, 95% CI 67.6 to 97.2), however the specificity was low and did not reach statistical significance (71.4%, 95% CI 29.3 to 95.5). In patients without dementia, three screening combinations had almost equivalent accuracy. Using MOTYB and SSF4, scenario (a), picked up 87.5% (95% CI 67.6 to 97.2) of delirium cases, and was 86.3% (95% CI 79.5 to 91.6) specific. Very similar results were achieved using either one of these tests simultaneously with seeking for evidence of ‘confusion’ (scenario 1). Table 3 displays a summary of the most diagnostically accurate approaches.
Delirium is vastly underdetected, a factor which contributes greatly to its long-term personal, social and economic burden. Most clinicians do not routinely screen for delirium in practice, possibly in part due to an underappreciation of its impact, but also due to a paucity of brief screening assessments.9 ,50 Most of the currently employed assessment techniques take longer than 5 min to perform,51 for example, the CAM, which in addition, requires training for accurate use.18 Recently, Han et al found that using a two-step screening process based on a brief operationalised version of the CAM (b-CAM) in the ED, had a sensitivity of 70.0–84.0% and a specificity of 95.8–97.2% when tested against DSM-IV diagnosis.52 The authors describe the b-CAM taking <1 min to perform, however, given that collateral history is required to assess temporal onset and fluctuations, it is likely that the process could often be more lengthy. In a similar vein, in this report, we describe the performance of a number of screening methods in the prediction of DSM-IV delirium across a large general hospital. We assessed three attention tests (MOTYB, SSF5, SSF4), as well as staff and patient's own impression of cognitive status. We examined the predictive potential of each screening method in isolation, followed by various screening combinations. Additionally, for each method, we assessed whether or not using the CAM as a second-line screening step improved accuracy. We also investigated if tailoring the approach depending on patient age, or prior cognitive status could improve efficiency.
The best overall individual screening test was MOTYB, with a sensitivity of 83.3% and a specificity of 90.8% for the entire group. The simultaneous addition of another screening method (either SSF4 or evidence of subjective/objective confusion), where any result being abnormal denoted a positive screen, increased net sensitivity to over 90%. Subanalysis in patients over and under the median age of 69 years, and in patients with and without dementia, gave similar results. In all subgroups, MOTYB performed well as an individual screening test, and in older patients or those with dementia, this approach was best. In younger patients or those without dementia, using MOTYB as part of a two-pronged screening approach, rather than alone, increased sensitivity without compromising specificity. It is also interesting to note that in younger patients, any evidence of confusion was highly predictive of delirium. This implies that formal attention testing may be less crucial in this group, as any evidence of confusion raises a strong suspicion of delirium. The SSF is a quick, simple attention test, which can be used in patients with expressive language difficulties. Using a cutoff of 5, it is a highly sensitive test for the presence of delirium, however, specificity is low at 69%. When the cutoff is lowered to 4, almost one-quarter of patients with delirium are missed. Nonetheless, this remains more accurate than staff detection (nursing staff missed one-third of cases, and medical staff failed to recognise one-half).1 These results are also consistent with previous work which illustrated that lower scores on the SSF are highly predictive of delirium, but higher scores are less useful in outruling its presence.37 Our study shows that the SSF appears to be particularly useful as a single test in patients with no prior history of dementia, when a cut-off of 5 yields a sensitivity of 91.7% and specificity of 75.5%.
As mentioned earlier, deficits in sustained attention occur in the late stages of AD, but performance on more complex attentional functions is impaired earlier in the disease.27 Some studies have used the MOTYB to distinguish stages of AD,53 ,54 including one small study which showed that the predictive value of the MMSE for dementia could be augmented by the addition of the MOTYB.53 In a study of multiple cognitive domains in patients with AD and fronto-temporal dementia (FTD), performance on Digit Span Forwards and Backwards and on Vigilance ‘A’ and ‘B’ tests was impaired to varying degrees in typical AD and FTD when compared with normal controls, whereas patients with amnestic AD were less affected.55 Interestingly, studies using more objective computerised attention tests have found that AD patients do not demonstrate impairments in focusing56 or sustained attention,38 whereas delirious patients are significantly impaired in this domain.38
In our study, although the SSF missed very few delirium cases in patients with dementia, even with a cut-off of 4, its specificity was below 50%. This indicates that the test is sensitive to cognitive impairment in general, and test failure may, in fact, be reflective of attentional deficits related to underlying dementia rather than delirium. MOTYB seemed more accurate at predicting delirium in the dementia group, however, results did not reach statistical significance, possibly due to small patient number (total n=31). Additionally, the low number of dementia patients who did not have delirium was very small (n=7) and, hence, interpretation of specificity in this subgroup is difficult. In practice, it is often challenging to ascertain premorbid cognition in patients who are acutely unwell, and who may have associated delirium or subsyndromal delirium, especially without a readily available, accurate collateral history. Hence, using different screening approaches depending on prior cognitive status may not be as easily applicable as, for example, varying the approach based on age, and supports the use of more versatile tools, such as MOTYB.
Our study has some limitations. Ideally, formal delirium testing should have been performed on all included patients, however, due to the time-consuming nature of thorough delirium assessment, it would not have been feasible to perform 265 such assessments over the course of 1 day. Hence, only those who had an indication of possible delirium, as detailed earlier, were formally assessed. It is possible that a patient with delirium may have passed both attention tests during a lucid interval, and had no other suggestion of possible delirium (ie, no subjective confusion or recollection of confusion during the lucid period, and no staff reports of potential delirium features). This is an unlikely scenario, thus, it can be assumed that those patients without formal delirium assessment did not have delirium. To manage time constraints and to ensure feasibility, we were unable to examine all existing bedside attention tests. Some other well-known tests of attention were not tested, for example, spelling the word WORLD backwards; subtracting serial sevens from 100; and counting backwards from 20 to 1. The former two, taken from the MMSE (Mini-Mental State Examination),30 rely heavily on level of education and mathematical ability57 and, hence, were thought not to be suitable in this cohort. Counting backwards from 20 to 1 is taken from the Abbreviated Mental Test Score developed by Hodkinson.58 This test seemed too straightforward for inclusion and likely to have a considerable ceiling effect. Therefore, it seemed more logical to us to use a more challenging test, such as the SSF. As mentioned above, due to feasibility, we did not use objective computerised tests of attention.
In all test scenarios, the addition of the CAM as a second-line screening step, before proceeding to full delirium assessment, resulted in reduced net sensitivity. Other studies have shown low CAM sensitivity when used by inexperienced and minimally trained raters.18 In this study, all those performing CAM ratings underwent rigorous training in its use, based on the CAM training manual.39 One of the cornerstones of CAM assessment is accurate, dependable collateral history and, in this study, the temporal nature and evidence of fluctuations for the purposes of CAM scoring was based mainly on collateral history from on-duty nursing staff. Poor awareness of delirium features among staff, or a lack of emphasis during staff handover, can hinder attempts to ascertain their presence or absence during CAM assessment and make it extremely challenging to pinpoint acuity of onset or degree of fluctuations. We believe that this issue was a major contributor to the reduced sensitivity of the CAM in this study. The difficulty in obtaining accurate collateral history is a well-recognised barrier to delirium recognition in practice.
Our study involved a single sample of hospital inpatients, and further studies are required to extrapolate our findings to other samples and populations. Nonetheless, we conclude that simple tests of attention may provide an efficient method of screening for delirium in the acute hospital setting. Our suggested approach towards screening for each patient subgroup is illustrated in figure 4. It is well established that the hospitalised elderly are very delirium prone, and our study suggests that using MOTYB may be particularly useful for screening in this population. In younger people at risk of delirium, using a combination of MOTYB and SSF4, where failing either test is a positive screen, is more sensitive. The SSF, being a non-verbal attention test, has greater coverage in populations with speech or communication deficits, for example, stroke patients with dysphasia (also at high risk of delirium). In patients with known cognitive impairment, screening using the methods outlined may not be as effective, but this group is especially at risk (77% in this study, but up to 89% in others59) and, hence, should undergo regular formal delirium testing during hospitalisation. In conclusion, we have described a novel, brief and straightforward screening approach for delirium detection across the general hospital. Our method requires minimal training and can be used by all healthcare professionals, including those with a limited understanding of delirium features. This brief approach to screening has the potential to greatly increase delirium recognition across the hospital, however, further prospective studies are needed to confirm our findings.
We wish to thank the nursing and junior medical staff of Cork University Hospital who assisted with this study.
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Files in this Data Supplement:
Contributors All authors meet ICJME criteria for authorship, and had full access to the data: All authors have substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data; drafting the article or revising it critically for important intellectual content; and final approval of the version to be published. NAO, DJR, JC, DM and ST: all substantially contributed to study conception and design, data collection, statistical analysis and interpretation, drafting the initial manuscript, and subsequent critical revision of the manuscript and final approval. JAE: assisted with statistical analysis, contributed to drafting the original manuscript, performed critical revisions and has approved the final manuscript. EB, WC, CMG and ML: all majorly involved in data acquisition, critical revisions and final approval of the manuscript. The lead author, Dr Niamh O'Regan, affirms that the manuscript is an honest, accurate and transparent account of the study, and that no important aspects or discrepancies have been omitted.
Competing interests All authors have completed the ICJME uniform disclosure form at http://www.icjme.org/coi_disclosure.pdf and declare: no support from any organisation for the submitted work; ST has received educational grants and honoraria from Janssen, Pfizer, Sanofi-Aventis, UCB, Astra-Zeneca, Orion, Lundbeck, Novartis, Boehinger, MSD pharmaceutical companies; no other relationships or activities that could appear to have influenced the submitted work.
Ethics approval This study was granted ethical approval by Cork Research Ethics Committee, Cork, Ireland.
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement No additional data is available